Blog

The Endocannabinoid System: A New Chapter in Human Biology

Understanding the Endocannabinoid System

The endocannabinoid system, often abbreviated ECS, became known through discoveries made in the late twentieth century. Its identification opened a new field of research into naturally occurring signaling molecules and their associated receptors and enzymes.

The Basic Components

The ECS takes its name from endocannabinoids, molecules produced within the body. Two of the best-studied are anandamide, abbreviated AEA, and 2-arachidonoylglycerol, abbreviated 2-AG.

Researchers also identified two classical cannabinoid receptors, known as CB1 and CB2. Receptors are proteins with which particular signaling molecules can interact.

Enzymes involved in producing and breaking down endocannabinoids are another part of the system. These include fatty acid amide hydrolase, or FAAH, and monoacylglycerol lipase, or MAGL.

Together, these molecules, receptors and enzymes form the core of what scientists traditionally describe as the ECS.

A Broader Research Vocabulary

As research progressed, scientists identified additional lipid molecules, receptors and enzymes associated with endocannabinoid signaling.

The term endocannabinoidome is sometimes used to describe this broader network. It reflects an expanding area of investigation rather than a single, universally fixed list of components.

Understanding these terms can help readers distinguish the original ECS framework from the broader concepts discussed in scientific publications.

Reading Cannabinoid Research

Scientific findings need to be understood in context. Research using isolated cells, laboratory models or animals does not establish what a finished consumer product will do in people. Findings about one molecule or formulation also cannot automatically be applied to another.

This article introduces scientific terminology and research history. It makes no claim about the effects or benefits of any Day Three Botanicals product.